Musings from The Power List: Peng Lu
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
False
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
September 4, 2026
2 min read
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
September 3, 2026
7 min read
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
August 28, 2026
2 min read
Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise
False
Affiliations:
Specialties:
Areas of Expertise: